Home › Funds › Opti Capital Management, LP › BMRN

Opti Capital Management, LP position in BMRN

BIOMARIN PHARMACEUTICAL INC COM · Health Care

Opti Capital Management, LP reported holding 28,058,000 shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM) in its Q2 2026 13F filing — a position valued at US$27.3M, representing 2.15% of its reported portfolio and ranking #19 among its reported holdings. Opti Capital Management, LP has disclosed BMRN holdings in 8 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)28.06M sh
Reported value held$27.34M
Portfolio Weight2.15%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opti Capital Management, LP's BMRN position evolved

Opti Capital Management, LP first disclosed a stake in BMRN in Q1 2024 at 7,600,000 shares (US$7.5M). The position peaked in Q4 2024 at 13,733,000 shares, worth US$12.81B. Across 8 filings, Opti Capital Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 28,058,000 shares valued at US$27.3M.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 7.60M $7.48M New
Q2 2024 7.60M $7.57M Hold
Q4 2024 13.73M $12.81B New
Q1 2025 13.73M $13.03M Hold
Q3 2025 32.06M $30.50M New
Q4 2025 32.06M $30.90M Hold
Q1 2026 28.06M $27.13M Reduce
Q2 2026 28.06M $27.34M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC COM) is a Health Care company. 27 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Opti Capital Management, LP held BMRN?

Opti Capital Management, LP has disclosed BMRN holdings in 8 of the last 10 reported quarters, going back to Q1 2024.

What is Opti Capital Management, LP's current position in BMRN?

As of Q2 2026, Opti Capital Management, LP holds 28.06M shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM), valued at $27.34M, representing 2.15% of its reported portfolio and ranking #19.

Has Opti Capital Management, LP been buying or selling BMRN?

In the latest 13F filing (Q2 2026), Opti Capital Management, LP held unchanged its position in BMRN. The position peaked in Q4 2024 at 13.73M shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.